China Life Insurance (NYSE:LFC) Rating Increased to Hold at Zacks Investment Research – MarketBeat
China Life Insurance (NYSE:LFC – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports.
According to Zacks, “China Life Insurance Company Limited is the leading life insurance company in China’s life insurance market. The Company provides products and services including individual life insurance, group life insurance, accident and health insurance. The Company is China’s largest life insurance company, a leading provider of annuity products and life insurance for both individuals and groups, and a leading provider of accident and health insurance. Through its controlling shareholding in the China Life Insurance Assets Management Co., Ltd., the Company became China’s largest insurance asset management company and one of the largest institutional investors in China. “
Shares of NYSE LFC opened at $7.17 on Wednesday. The firm has a market capitalization of $40.53 billion, a price-to-earnings ratio of 5.09, a PEG ratio of 0.39 and a beta of 0.92. The stock has a 50 day moving average price of $8.61 and a 200 day moving average price of $8.56. China Life Insurance has a 52-week low of $6.99 and a 52-week high of $10.79.
(Ad)
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.
Take your trading to the next level with the Options Strategy Guide.
A number of institutional investors have recently bought and sold shares of LFC. D Orazio & Associates Inc. acquired a new position in shares of China Life Insurance during the third quarter worth $25,000. Fieldpoint Private Securities LLC increased its position in shares of China Life Insurance by 8,265.2% in the 4th quarter. Fieldpoint Private Securities LLC now owns 9,620 shares of the financial services provider’s stock valued at $79,000 after acquiring an additional 9,505 shares during the period. CAPROCK Group Inc. acquired a new position in shares of China Life Insurance in the 3rd quarter valued at $82,000. O Shaughnessy Asset Management LLC increased its position in shares of China Life Insurance by 328.9% in the 3rd quarter. O Shaughnessy Asset Management LLC now owns 11,018 shares of the financial services provider’s stock valued at $90,000 after acquiring an additional 8,449 shares during the period. Finally, Pinnacle Wealth Planning Services Inc. acquired a new position in shares of China Life Insurance in the 4th quarter valued at $97,000. Institutional investors own 8.12% of the company’s stock.
China Life Insurance Company Profile (Get Rating)
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People’s Republic of China. It operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses. The company offers individual and group life, annuity products, accident, and health insurance products.
See Also
Get a free copy of the Zacks research report on China Life Insurance (LFC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $1,000 in China Life Insurance right now?
Before you consider China Life Insurance, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and China Life Insurance wasn’t on the list.
While China Life Insurance currently has a “N/A” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
